Richard J. Rubino
2014
In 2014, Richard J. Rubino earned a total compensation of $1.9M as Chief Financial Officer, Secretary at Aerie Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Bonus | $205,313 |
|---|---|
| Option Awards | $1,293,924 |
| Salary | $365,000 |
| Total | $1,864,237 |
Rubino received $1.3M in option awards, accounting for 69% of the total pay in 2014.
Rubino also received $205.3K in bonus and $365K in salary.
Rankings
In 2014, Richard J. Rubino's compensation ranked 4,798th out of 13,032 executives tracked by ExecPay. In other words, Rubino earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,798 out of 13,032 | 63rd |
Division Manufacturing | 1,715 out of 4,966 | 66th |
Major group Chemicals And Allied Products | 563 out of 1,686 | 67th |
Industry group Drugs | 430 out of 1,365 | 69th |
Industry Biological Products, Except Diagnostic Substances | 72 out of 236 | 70th |
Source: SEC filing on April 29, 2016.
Rubino's colleagues
We found three more compensation records of executives who worked with Richard J. Rubino at Aerie Pharmaceuticals in 2014.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019